COAGULOPATHY
Clinical trials for COAGULOPATHY explained in plain language.
Never miss a new study
Get alerted when new COAGULOPATHY trials appear
Sign up with your email to follow new studies for COAGULOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New Quick-Acting powder could save lives in severe trauma bleeding
Disease control Recruiting nowThis study tests whether a fast-to-use fibrinogen powder can control bleeding as well as or better than the standard frozen blood product (cryoprecipitate) in severely injured trauma patients. About 900 adults in Australia and New Zealand who need emergency blood transfusions and…
Matched conditions: COAGULOPATHY
Phase: PHASE3 • Sponsor: Australian and New Zealand Intensive Care Research Centre • Aim: Disease control
Last updated May 17, 2026 14:12 UTC
-
New drug aims to tame deadly clots in sepsis
Disease control Recruiting nowThis early-stage study tests a new medicine called BAY 3389934 in up to 36 adults with sepsis who have blood clotting issues. The goal is to find a safe dose and see how the drug affects the body. Participants are in the ICU and will be monitored for about 28 days.
Matched conditions: COAGULOPATHY
Phase: PHASE1 • Sponsor: Bayer • Aim: Disease control
Last updated May 17, 2026 14:11 UTC
-
New blood test for kids: how well does it work?
Knowledge-focused Recruiting nowThis study looks at how a new device called TEG 6s measures blood clotting in healthy children. About 125 kids having planned surgery will give a small blood sample. The goal is to find normal values for children and compare them to published ranges. No treatment or medication is…
Matched conditions: COAGULOPATHY
Phase: NA • Sponsor: Indiana University • Aim: Knowledge-focused
Last updated May 17, 2026 14:15 UTC